Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from Synnovation

Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from…


Immunology

Immunology Today—March 18, 2026

This week’s Immunology update highlights regulatory progress, late-stage…


Neuroscience

Neuroscience Today—March 4, 2026

This week's Neuroscience update covers key developments across late-stage…


Immunology

Immunology Video Recap—February 25, 2026

This biweekly Immunology video recap highlights key developments across…


Immunology

Immunology Today—February 25, 2026

This week's Immunology update summarizes covering clinical-trial readouts and…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide licensing agreement

Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide…


Onco_background

Oncology Today—February 9, 2026

This week's Oncology update , covers regulatory actions, late-stage clinical…


Neuroscience

Neuroscience Video Recap—February 4, 2026

This biweekly Neuroscience video recap covers key updates, including regulatory…


Neuroscience

Neuroscience Today—February 4, 2026

This week's Neuroscience update summarizes key developments in clinical…


Immunology

Immunology Video Recap—January 28, 2026

This biweekly Immunology video recap highlights key regulatory actions,…


Neuroscience

Neuroscience Video Recap—January 21, 2026

This Neuroscience video recap highlights key developments across regulatory…


Immunology

Immunology Today—January 21, 2026

This week's Immunology edition covers major regulatory milestones, late-stage…


Privacy Preference Center